Health
SFRP2 and PD-1 immunotherapy combination halts osteosarcoma metastasis in model – EurekAlert
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist…
IMAGE: Hollings Cancer Center researcher Nancy Klauber-DeMore, M.D., is leading the first breakthrough in pediatric osteosarcoma treatment in decades.
view more
Credit: MUSC Hollings Cancer Center/Marquel Coaxum
In a cancer that has not seen new targeted…
Continue Reading
-
Business23 hours agoSilver reaches a 14-year high. Will it outperform the gold price this year?
-
General24 hours ago‘Golden ticket’ visa for the rich fails to pay its way
-
Business23 hours ago3 ASX ETFs for beginners (and experts) to buy and forget
-
Business24 hours agoWhy Macquarie expects this surging ASX 200 gold stock could leap another 40%